Top Tweets for #ImmixBio

about 1 year ago

Immix Biopharma Further Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2 $IMMX, #ImmixBiopharma, #ImmixBio https://t.co/2hw0pDWCz2

Hottest Stocks Now @HottestStockNow

about 1 year ago

Immix Biopharma to reveal interim clinical data from the NEXICART-2 Phase 1/2 clinical trial of cell therapy NXC-201 in patients with relapsed/refractory AL Amyloidosis $IMMX, #ImmixBiopharma, #ImmixBio, #Immix https://t.co/tOmPH9Up67

155

1stOncology @1stOncology

about 4 years ago

#ImmixBio #IMX110 Demonstrated Improved Survival Over U.S. Food and Drug Administration Approved Drug #Trabectedin (sold as #YONDELIS by #Janssen a Johnson & Johnson Company) in #ConnectiveTissue #Cancer #SoftTissueSarcoma Mice Study $IMMX https://t.co/vJ3XkIPKDn

dot.LA

@dotLA

about 5 years ago

#ImmixBio, a West L.A.-based startup developing cancer therapies, announced on Friday it submitted a confidential filing to go public. #biotech #techLA #longLA #IPO https://t.co/Z5vxgSgoox

Top Tweets for #ImmixBio

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users